Abstract
Microneedle technology has emerged as a significant advancement in medical science, revolutionizing approaches to vaccine delivery, chronic disease management, and dermatological treatments. Its minimal invasiveness, ease of use, and potential to enhance healthcare access are particularly beneficial in resource-limited settings. The application of this technology spans various domains such as simplifying vaccination processes, facilitating non-invasive chronic disease monitoring, and improving the delivery of dermatological treatments. Recent studies have demonstrated the potential to increase vaccination rates, provide pain-free chronic disease management, and offer efficient drug delivery systems in dermatology and cancer treatments. However, certain challenges remain, including overcoming social stigma, regulatory hurdles, and manufacturing issues. Continued research and collaboration are essential to overcome these barriers and realizing the full potential of microneedle technology in transforming healthcare.
Keywords:
Microneedle technology, vaccine delivery, chronic disease management, non-invasive monitoring, drug delivery systemsReferences
Bao Z, Lu S, Zhang D, Wang G, Cui X, Liu G. Wearable Microneedle Patch for Colorimetric Detection of Multiple Signature Biomarkers in vivo Toward Diabetic Diagnosis. Adv Healthc Mater. 2024:e2303511.
Umesh DJ, Dhanashree UJ, Sohel MS, Yuvraj PS, Shreya SK, Shweta SH, et al. Microneedles : A Smart Approach for Transdermal Drug Delivery System. International Journal of Scientific Research in Science and Technology. 2023:612-23.
Zhao ZQ, Liang L, Jing LY, Liu Y, Zhang YH, Shahbazi M-A, et al. Microneedles: a novel strategy for wound management. Biomater Sci. 2023;11(13):4430-51.
Feng Y-X, Hu H, Wong Y-Y, Yao X, He M-L. Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination. Pharmaceutics. 2023;15(5):1349.
Dugad B, Bhattacharya S. The Microneedle Drug Delivery System and some Recent Obstacles in its Implementation. Nanoscience & Nanotechnology-Asia. 2023;13(4):28-46.
Laskar TT, Arora M. Microneedles: Recent advances and development in the field of transdermal drug delivery technology. J Drug Delivery Ther. 2023;13(3):155-63.
Ganeson K, Alias AH, Murugaiyah V, Amirul A-AA, Ramakrishna S, Vigneswari S. Microneedles for Efficient and Precise Drug Delivery in Cancer Therapy. Pharmaceutics. 2023;15(3):744.
De Decker I, Logé T, Hoeksema H, Speeckaert MM, Blondeel P, Monstrey S, et al. Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review. J Dermatol. 2023;50(4):422-44.
Nguyen HX, Nguyen CN. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals. Pharmaceutics. 2023;15(1):277.
Luo X, Yang L, Cui Y. Microneedles: materials, fabrication, and biomedical applications. Biomed Microdevices. 2023;25(3):20.
Münch S, Wohlrab J, Neubert RHH. Dermal and transdermal delivery of pharmaceutically relevant macromolecules. Eur J Pharm Biopharm. 2017;119:235-42.
Lee W-R, Shen S-C, Al-Suwayeh SA, Yang H-H, Li Y-C, Fang J-Y. Skin Permeation of Small-Molecule Drugs, Macromolecules, and Nanoparticles Mediated by a Fractional Carbon Dioxide Laser: The Role of Hair Follicles. Pharm Res. 2012;30(3):792-802.
Becker S, Zorec B, Miklavčič D, Pavšelj N. Transdermal transport pathway creation: Electroporation pulse order. Math Biosci. 2014;257:60-8.
Masterson J, Kluge B, Burdette A, Sr GL. Sustained Acoustic medicine; Sonophoresis for Nonsteroidal anti-inflammatory Drug Delivery in Arthritis. Therapeutic Delivery. 2020;11(6):363-72.
Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol. 2004;22(2):192-7.
Rawat S, Vengurlekar S, Rakesh B, Jain S, Srikarti G. Transdermal delivery by iontophoresis. Indian J Pharm Sci. 2008;70(1):5.
Vaseem RS, D’cruz A, Shetty S, Hafsa, Vardhan A, R SS, et al. Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement. Adv Pharm Bull. 2024;14(1):67.
Ruan S, Li J, Ruan H, Xia Q, Hou X, Wang Z, et al. Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment. J Controlled Release. 2024;366:712-31.
Lin H, Liu J, Hou Y, Yu Z, Hong J, Yu J, et al. Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs. Drug Deliv Transl Res. 2024:1-5.
Yang F, Wang W, Zhou J, Yu Z, An M, He W, et al. Transdermal delivery of IBU-PLGA nanoparticles with dissolving microneedle array patch. Journal of Drug Delivery Science and Technology. 2024; 95:105528.
Adigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, et al. A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. The Lancet. 2024;403(10439):1879-92.
Zhao C, Wu Z, Pan B, Zhang R, Golestani A, Feng Z, et al. Functional biomacromolecules-based microneedle patch for the treatment of diabetic wound. Int J Biol Macromol. 2024;267(Pt 2):131650.
Lyu S, Liu Q, Yuen HY, Xie H, Yang Y, Yeung KW, et al. A differential-targeting core-shell microneedle patch with coordinated and prolonged release of mangiferin and MSC-derived exosomes for scarless skin regeneration. Mater Horiz. 2024;11(11):2667-84.
Nogueira AS, Garcia MAC, Silva MBD, Costa PFD, Frade MAC, Salgado CG, et al. Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study. Trop Med Int Health. 2024;29(4):327-33.
Azizi Machekposhti S, Khanna S, Shukla S, Narayan R. Microneedle fabrication methods and applications. MRS Communications. 2023;13(2):212-24.
Malek-Khatabi A, Sadat Razavi M, Abdollahi A, Rahimzadeghan M, Moammeri F, Sheikhi M, et al. Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery. Biomater Sci. 2023;11(16):5390-409.
How to Cite
License
Copyright (c) 2024 Neha Bajwa, Vighnesh Devulapalli, Mahendra Pratap Singh, Kumbha Gopi, Sanobar Shariff, Pavan Kumar, Carlos Quispe-Vicuña
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright© by the author(s). Published by the Evidence Journals. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Most read articles by the same author(s)
- AB Amaljith, Debankur Dey, Mirza Adil Beig, Mithun Mohan George , Dipanshu Aggarwal , Pavan Kumar , Sai Mahesh Vajjala, Aditi Pal, Tanya Gupta, Suneeti Kanyari S , Vineeth Rajagopal, Anemia, a risk factor for gastroenteritis among the elderly in India: evidence from the LASI cohort , The Evidence: Vol. 2 No. 3 (2024): JUL - SEP
- Vansh Maheshwari, Parul Chawla Gupta, Hashem Abu Serhan, Dipanshu Aggarwal, Ram Sumit, Gopi Kumbha, Neha Bajwa, Prevalence and determinants of vision problems among community-dwelling older adults with diabetes: evidence from longitudinal ageing study in India (2017-18) , The Evidence: Vol. 2 No. 2 (2024): APR - JUN
- Dipanshu Aggarwal, Mahendra Pratap Singh, Anoop Velayudhan, Safayet Jamil, Carlos Quispe-Vicuña, Afukonyo Shidoiku Daniel, Joseph Clement Chipeta, Gopi Kumbha, Pooja Sindwani, The lasting impact of COVID-19: autonomic dysfunctions and their implications for future healthcare , The Evidence: Vol. 2 No. 1 (2024): JAN - MAR
- Neha Shri, Aditya Singh, Sowmiya Nehrudurai, Vimal Singh Munda, Denny Mathew John, Riyaz Ahamed shaik, Vijay Tadia, Amit Kumar, Pavan Kumar, Gurmanjeet Kaur, Ananya Kundu, Trends and patterns in dengue incidence and mortality across India and its states from 1990 to 2019: insights from the Global Burden of Disease study 2019 , The Evidence: Vol. 2 No. 4 (2024): OCT - DEC
